Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Bioorganicheskaia Khimiia|October 26, 2005
[Theoretical conformational analysis in the determination of productive conformations of substrates for acetylcholinesterase and butyrylcholinesterase]D A Belinskaia, N N ShestakovaBioorganicheskaia Khimiia|June 10, 2010
[The role of electrostatic interactions in the absorption of ligands to the active sites of cholinesterases, as indicated by molecular modeling data]D A Belinskaia, A H Juffer, N N ShestakovaJournal of Evolutionary Biochemistry and Physiology|December 27, 2021
Integrative Role of Albumin: Evolutionary, Biochemical and Pathophysiological AspectsD A Belinskaia, P A Voronina, N V GoncharovBioorganicheskaia Khimiia|April 22, 2015
[Serum albumin: search for new sites with esterase activity according to molecular modeling data]D A Belinskaia, V I Shmurak, D S Prokof'eva, et al.Bulletin of Experimental Biology and Medicine|August 10, 2023
Benzimidazole-Carboxamides as Potential Therapeutics for Alzheimer's Disease: Primary Analysis In Silico and In VitroYu V Chelusnova, P A Voronina, D A Belinskaia, et al.Bioorganicheskaia Khimiia|July 14, 2015
[On the Enzymatic Activity of Albumin]N V Goncharov, D A Belinskaia, A V Razygraev, et al.Journal of Evolutionary Biochemistry and Physiology|May 23, 2022
Erratum to: Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1)N V Goncharov, K A Vasilyev, I V Kudryavtsev, et al.Journal of Evolutionary Biochemistry and Physiology|March 14, 2022
Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1)N V Goncharov, K A Vasilyev, I V Kudryavtsev, et al.Pageof 1